Teija Sainio
Papers
2
Total Citations
38
H-Index
2
About
Teija Sainio is a leading researcher in the field of interventional oncology, with a primary focus on the development and clinical translation of MRI-guided transurethral ultrasound ablation (TULSA) for the treatment of localized prostate cancer. Her major contributions center on establishing the feasibility, safety, and imaging-based assessment of this minimally invasive technique. In her seminal 2019 study, Sainio demonstrated the safety and accuracy of lesion-targeted TULSA, showing that the procedure could precisely ablate cancerous tissue with acceptable toxicity, a work that has garnered 30 citations and laid the groundwork for broader clinical adoption. She further advanced the field by providing the first detailed characterization of acute and subacute prostate MRI findings following TULSA, offering critical insights into the temporal evolution of post-ablation cell death and tissue changes. This work is essential for radiologists and urologists interpreting post-treatment imaging. Through her research, Sainio has helped pioneer a paradigm shift toward more precise, image-guided, and organ-sparing treatments, directly impacting the clinical management of prostate cancer and improving patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2